PPIP5K1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.642200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.632170E-01
Normal-vs-Stage2
7.345000E-01
Normal-vs-Stage3
2.758400E-01
Normal-vs-Stage4
2.490600E-01
Stage1-vs-Stage2
2.377700E-02
Stage1-vs-Stage3
2.240300E-02
Stage1-vs-Stage4
4.786800E-01
Stage2-vs-Stage3
1.111430E-01
Stage2-vs-Stage4
3.369800E-01
Stage3-vs-Stage4
2.267600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.635400E-01
Normal-vs-AfricanAmerican
5.683400E-01
Normal-vs-Asian
8.948800E-01
Caucasian-vs-AfricanAmerican
9.018800E-01
Caucasian-vs-Asian
5.754200E-01
AfricanAmerican-vs-Asian
6.204600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.743600E-01
Normal-vs-Female
6.560400E-01
Male-vs-Female
5.842600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.928200E-01
Normal-vs-Age(41-60Yrs)
4.760800E-01
Normal-vs-Age(61-80Yrs)
7.529800E-01
Normal-vs-Age(81-100Yrs)
8.529200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.340400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.492620E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.482200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.181400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.913700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.707800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.977600E-01
Normal-vs-Daily Drinker
5.863400E-01
Normal-vs-Weekly Drinker
9.353200E-01
Normal-vs-Occasional Drinker
4.440200E-01
Normal-vs-Social Drinker
5.875600E-01
Non Drinker-vs-Daily Drinker
1.909040E-01
Non Drinker-vs-Weekly Drinker
8.707000E-01
Non Drinker-vs-Occasional Drinker
8.142100E-02
Non Drinker-vs-Social Drinker
2.558200E-01
Daily Drinker-vs-Weekly Drinker
2.485400E-01
Daily Drinker-vs-Occasional Drinker
3.617800E-01
Daily Drinker-vs-Social Drinker
9.206000E-01
Weekly Drinker-vs-Occasional Drinker
8.404400E-02
Weekly Drinker-vs-Social Drinker
2.850600E-01
Occasional Drinker-vs-Social Drinker
3.718400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.162100E-02
Normal-vs-Grade 2
3.101200E-03
Normal-vs-Grade 3
2.863000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.113000E-01
Grade 1-vs-Grade 3
5.347200E-01
Grade 1-vs-Grade 4
7.162100E-02
Grade 2-vs-Grade 3
7.974600E-01
Grade 2-vs-Grade 4
3.101200E-03
Grade 3-vs-Grade 4
2.863000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.562000E-01
Normal-vs-NonDiabetic
6.064800E-01
Diabetic-vs-NonDiabetic
6.837700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.987000E-01
Normal-vs-NoPancreatitis
7.357000E-01
Pancreatitis-vs-NoPancreatitis
3.965600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.355200E-01
Normal-vs-N1
7.621000E-01
N0-vs-N1
1.165800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.266600E-01
Normal-vs-TP53-NonMutant
4.778800E-01
TP53-Mutant-vs-TP53-NonMutant
4.103600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
